Abstract
Background: Inhibitors targeting immune checkpoint were proved effective in cancer immunotherapy, such as PD-1/PD-L1 blockade. The novel immune checkp......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
